Showing posts with label FDA warning. Show all posts
Showing posts with label FDA warning. Show all posts
Tuesday, July 13, 2010
Tuesday, June 01, 2010
Tuesday, January 26, 2010
NCI clincial trial: A Targeted Phase I/II Trial of ZD6474 (Vandetanib; ZACTIMA) Plus the Proteasome Inhibitor, Bortezomib (Velcade(Registered Trademark)), in Adults With Solid Tumors With a Focus on Hereditary or Sporadic, Locally Advanced or Metastatic Medullary Thyroi... - Full Text View - ClinicalTrials.gov
Drug: VELCADE, PS-341 (Bortezomib, NSC #681239) Drug: ZACTIMA (Vandetanib) (ZD6474) Phase I Phase II
add your opinions
Bortezomib
,
clinical trial
,
FDA warning
,
PS-341
,
Velcade
,
ZD6474
Subscribe to:
Posts
(
Atom
)